Navigation Links
MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination

DENVER, CO, May 21 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) (, MIT is pleased to announce that it has signed the Joint Venture Agreement with its Chinese partners.

MIT president Mr. Karim Menassa has returned from his most recent trip to China having completed the negotiations and finalized an agreement for a joint venture. MIT has also received an initial order of 120 Agro-Jet(R) for vaccination of livestock and poultry from the joint venture.

The name of the joint venture company is "Jiangsu Hualan MIT Medical Technology (MIT China) Ltd" and will be located in Taizhou city in the Jiangsu province. This prime location, supported by the central government, will become the most important medical city in China through the relocation of the pharmaceutical and medical devices corporations. MIT Canada will have 49% equity in "Jiangsu Hualan MIT Medical Technology (MIT China) Ltd". The total investment by both parties will be US$ 1.4 million dollars.

All the legal documents for the incorporation and licenses for the manufacturing of all MIT products are being finalized and we expect to start assembling the Agro-Jet models in China beginning in September 2009 for the sales to the Chinese market. MIT Canada will continue to produce and supply most of the components for the joint venture.

This joint venture agreement will help Medical International Technologies (MIT Canada) Inc. become a world leader in the Needle-Free technology and reduce the world's dependence on needles. Moreover, it will ensure that MIT injectors become an indispensable, environmentally friendly product for single and mass vaccination and biologics injectables for doctors and users around the world. MIT's mission is to help make the world needle-free.

Medical International Technology Inc. is pleased to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

Karim Menassa, President

On Behalf of the Board of Directors

Tel: 514-339-9355

About Medical International Technology, Inc.

MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AdvaMed Pleased to Work with the White House to Advance Health Reform
2. MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners
3. AARP Pennsylvania Pleased by House Committee Action
4. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
5. RADinfo SYSTEMS(TM) is Pleased to Introduce Their Newly Established Division, VETinfo SYSTEMS(TM)
6. Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
7. Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
8. Texas Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
9. Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Womans World Magazine
10. Patients Pleased With Laparoscopic GERD Surgery
11. Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... ... 2015 , ... According to an article published November 15th by ... handling security in light of the recent terrorist attacks in Paris, other cities are ... an attack from reaching U.S. soil. Especially around special events that may be high-profile ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Linden Care, ... and optimizing treatment outcomes for patients suffering from chronic ... request for a Temporary Restraining Order (TRO) enjoining Express ... the two companies. --> ... pursuing all of its legal options. ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology: